Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06485778 · ClinicalTrials.gov registry record · Phase 2
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
A Phase 2 study of Oral Tongue Squamous Cell Carcinoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 7
- Study locations
NCT06485778 is a Phase 2 study of Oral Tongue Squamous Cell Carcinoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 24 participants. The trial reports 7 study locations across 2 states.
The verdict
NCT06485778, a Phase 2 study of Oral Tongue Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study will test whether limiting standard photon intensity modulated radiation therapy (IMRT) to exclude the oral tongue surgical site can decrease the risk of side effects caused by oral radiation. The researchers will also find out if this approach affects the rate of disease coming back after treatment (recurrence), and will measure participants' quality of life by having them complete questionnaires.
Conditions Studied
Interventions
- RADIATION Photon intensity modulated radiation therapy (IMRT)
- OTHER Life questionnaire's
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-06-27 |
| Est. Completion | 2026-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06485778
The ClinicalTrials.gov registry entry for NCT06485778 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Tongue Squamous Cell Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Photon intensity modulated radiation therapy (IMRT) is the first listed.
NCT06485778 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06485778 about?
NCT06485778 is a clinical study titled "A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma". This study will test whether limiting standard photon intensity modulated radiation therapy (IMRT) to exclude the oral tongue surgical site can decrease the risk of side effects caused by oral radiation. The researchers will also find out if this approach affects the rate of disease coming back afte...
What is the current status of trial NCT06485778?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2024-06-27. Estimated completion is 2026-06.
What conditions does trial NCT06485778 study?
This clinical trial studies the following conditions: Oral Tongue Squamous Cell Carcinoma.
What interventions are being tested in trial NCT06485778?
The interventions under investigation include: Photon intensity modulated radiation therapy (IMRT) (RADIATION), Life questionnaire's (OTHER).
Who is sponsoring clinical trial NCT06485778?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06485778 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.